A new frontier in knee Osteoarthritis treatment comes to North Wales

Spire Yale Hospital and Chesney Courtare offering a non-surgical option for knee osteoarthritis treatment for patients suffering from debilitating pain from osteoarthritis.

Currently, surgery remains a most reliable option to treat knee osteoarthritis in patients who exhausted all non-operative treatments. Although there are number of patients who are either not suitable for surgery, fit for the surgery or not keen to have a major operation for various reasons. Unfortunately, options are extremely limited for such patients apart from very strong and potentially harmful painkillers. This innovative Arthrosamid injection provides mechanical support but also reduces inflammation. This dual action helps in alleviating pain and improving mobility, offering patients a potential long-term solution to OA symptoms.

Osteoarthritis (OA) is a degenerative joint disease characterised by the breakdown of cartilage, leading to pain, stiffness, and reduced mobility. As one of the most common forms of arthritis, it significantly impacts the quality of life for millions of individuals worldwide. Despite the prevalence of OA, treatment options remain limited, focusing primarily on pain management, physical therapy, and ultimately, surgical intervention.

Staff Nurse Genevieve Lachica, Hospital Director Angie Wallace, Radiologist and specialist in knee injections Dr Patel, Consultant Orthopaedic Surgeon and specialist in knee injections Professor Ibrahim Malek and Outpatient Clinical Lead Adrian Jones.